Announcements Trials
Browse Landscape

Phase

Phase 2 77Phase 3 47Phase 1 31Phase 1/2 16Phase NA 8Phase 2/3 7Phase 4 3Phase EARLY_PHASE1 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Other 1

Conditions

Pancreatic Neoplasms 4Colonic Neoplasms 2Stomach Neoplasms 1Neuritis 1Mucositis 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1Borderline Resectable Pancreatic Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 3Fluorouracil 3Oxaliplatin 2Leucovorin 2Cholecalciferol 2Cetuximab 2sodium thiosulfate 1nilotinib 1gallium 68 PSMA-11 1epigallocatechin gallate 1delta-8-tetrahydrocannabinol 1clevudine 1X-Rays 1Vaccines 1Tea 1Specimen Handling 1Reverse Transcriptase Polymerase Chain Reaction 1Receptor Protein-Tyrosine Kinases 1Radiotherapy 1Platinum 1Pentoxifylline 1Panitumumab 1Microscopy, Electron 1Metastasectomy 1Irinotecan 1Hyperthermic Intraperitoneal Chemotherapy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Folfox protocol 1Fluorodeoxyglucose F18 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Colonic Neoplasms × Oxaliplatin × Clear all
NCT06011772 2026-03-11

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

Roswell Park Cancer Institute

Phase EARLY_PHASE1 Active not recruiting
2 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05590117 2022-10-21

Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer

Tanta University

Phase EARLY_PHASE1 Unknown
48 enrolled
GastrointestinalOther

Colonic Neoplasms, Neuritis, Colorectal Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡